EXPD vs PROF · P/E 26, rev $10.60B vs rev $10.7M
Expeditors International of Washington, Inc. (EXPD) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. PROF currently screens at market cap $238.7M.
Not investment advice. Open the EXPD and PROF stock pages for the full models.
Not investment advice.